IP Library Granted Patent US 7,067,250
Granted Patent B1
US 7,067,250 · App. 09/137,944 · Granted Jun 27, 2006

Extracellular serine protease

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,067,250
App. No.
09/137,944
Granted
Jun 27, 2006
Kind
B1
Abstract

The present invention provides a DNA encoding a TADG-14 protein selected from the group consisting of: (a) isolated DNA which encodes a TADG-14 protein; (b) isolated DNA which hybridizes to isolated DNA of (a) above and which encodes a TADG-14 protein; and (c) isolated DNA differing from the isolated DNAs of (a) and (b) above in codon sequence due to the degeneracy of the genetic code, and which encodes a TADG-14 protein. Also provided is a vector capable of expressing the DNA of the present invention adapted for expression in a recombinant cell and regulatory elements necessary for expression of the DNA in the cell.

Claims (3)

1. A method of detecting expression of mRNA transcribed from the DNA encoding a Tumor Antigen Derived Gene-14 TADG-14) protein comprising the steps of:

(a) contacting mRNA obtained from a cell with a labeled hybridization probe having a sequence complementary to SEQ ID No: 6; and

(b) detecting hybridization of said probe with said mRNA, wherein the presence of hybridization is indicative of the expression of mRNA transcribed from the DNA encoding TADG-14 protein.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2017
From: BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
To: BIOVENTURES, LLC
Reel/Frame 044037/0496 →